Laminin-332-rich tumor microenvironment for tumor invasion in the interface zone of breast cancer

American Journal of Pathology

Volumn 178, Issue 1, 2011, Pages 373-381

  Kim, Baek Gil ^a   An, Hee Jung ^b   Kang, Suki ^a   Choi, Yoon Pyo ^a   Gao, Ming Qing ^a   Park, Haengran ^a   Cho, Nam Hoon ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Pundang CHA Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; KALININ; MICRORNA; NERVE CELL ADHESION MOLECULE; STROMELYSIN; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG; ZINC FINGER E BOX BINDING HOMEOBOX 1; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST FIBROSIS; CANCER INVASION; CANCER SURVIVAL; CANCER TISSUE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MYOFIBROBLAST; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; TUMOR MICROENVIRONMENT; TUMOR VOLUME;

EID: 79251509924     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.028     Document Type: Article

References (33)

1. Liotta LA, Kohn EC: The microenvironment of the tumour-host interface. Nature 2001, 411:375-379
2. Montel V, Mose ES, Tarin D: Tumor-stromal interactions reciprocally modulate gene expression patterns during carcinogenesis and metastasis. Int J Cancer 2006, 119:251-263 (Pubitemid 43911887)
3. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S: Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 2005, 241:629-639
4. Radisky DC, Kenny PA, Bissell MJ: Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 2007, 101:830-839
5. Hinz B: Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 2009, 11:120-126
6. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127
7. Radisky DC, Przybylo JA: Matrix metalloproteinase-induced fibrosis and malignancy in breast and lung. Proc Am Thorac Soc 2008, 5:316-322
8. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M, Yu DY: Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 2001, 61:984-990
9. Cao J, Chiarelli C, Richman O, Zarrabi K, Kozarekar P, Zucker S: Membrane type 1 matrix metalloproteinase induces epithelial-to-mesenchymal transition in prostate cancer. J Biol Chem 2008, 283:6232-6240
10. Xouri G, Christian S: Origin and function of tumor stroma fibroblasts, Semin Cell Dev Biol 21:40-46
11. Mizushima H, Miyagi Y, Kikkawa Y, Yamanaka N, Yasumitsu H, Misugi K, Miyazaki K: Differential expression of laminin-5/ladsin subunits in human tissues and cancer cell lines and their induction by tumor promoter and growth factors. J Biochem 1996, 120:1196-1202
12. Berndt A, Hyckel P, Konneker A, Katenkamp D, Kosmehl H: Oral squamous cell carcinoma invasion is associated with a laminin-5 matrix re-organization but independent of basement membrane and hemidesmosome formation. Clues from an in vitro invasion model. Invasion Metastasis 1997, 17:251-258
13. Giannelli G, Fransvea E, Bergamini C, Marinosci F, Antonaci S: Laminin- 5 chains are expressed differentially in metastatic and nonmetastatic hepatocellular carcinoma. Clin Cancer Res 2003, 9:3684-3691
14. Martin KJ, Kwan CP, Nagasaki K, Zhang X, O'Hare MJ, Kaelin CM, Burgeson RE, Pardee AB, Sager R: Down-regulation of laminin-5 in breast carcinoma cells. Mol Med 1998, 4:602-613
15. Hao J, Jackson L, Calaluce R, McDaniel K, Dalkin BL, Nagle RB: Investigation into the mechanism of the loss of laminin 5 (alpha3beta3gamma2) expression in prostate cancer. Am J Pathol 2001, 158:1129-1135
16. Pullar CE, Baier BS, Kariya Y, Russell AJ, Horst BA, Marinkovich MP, Isseroff RR: beta4 Integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. Mol Biol Cell 2006, 17:4925-4935 (Pubitemid 44665760)
17. Guo W, Giancotti FG: Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 2004, 5:816-826
18. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S: Laminin- 5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005, 129:1375-1383
19. Hurteau GJ, Spivack SD, Brock GJ: Potential mRNA degradation targets of hsa-miR-200c, identified using informatics and qRT-PCR. Cell Cycle 2006, 5:1951-1956
20. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR: Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 1999, 59:5002-5011
21. Bissell MJ, Radisky D: Putting tumours in context. Nat Rev Cancer 2001, 1:46-54
22. Weaver VM, Fischer AH, Peterson OW, Bissell MJ: The importance of the microenvironment in breast cancer progression: recapitulation of mammary tumorigenesis using a unique human mammary epithelial cell model and a three-dimensional culture assay. Biochem Cell Biol 1996, 74:833-851
23. Marinkovich MP: Tumour microenvironment: laminin 332 in squamous- cell carcinoma. Nat Rev Cancer 2007, 7:370-380
24. Miyazaki K: Laminin-5 (laminin-332): unique biological activity and role in tumor growth and invasion. Cancer Sci 2006, 97:91-98
25. Carpenter PM, Dao AV, Arain ZS, Chang MK, Nguyen HP, Arain S, Wang-Rodriguez J, Kwon SY, Wilczynski SP: Motility induction in breast carcinoma by mammary epithelial laminin 332 (laminin 5). Mol Cancer Res 2009, 7:462-475
26. Flier SN, Tanjore H, Kokkotou EG, Sugimoto H, Zeisberg M, Kalluri R: Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis. J Biol Chem 2010, 285:20202-20212
27. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, Nikolic- Paterson DJ, Atkins RC, Lan HY: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998, 54:864-876
28. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, Neilson EG: Identification and characterization of a fibroblast marker: fSP1. J Cell Biol 1995, 130:393-405
29. Munshi HG, Wu YI, Mukhopadhyay S, Ottaviano AJ, Sassano A, Koblinski JE, Platanias LC, Stack MS: Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor-beta1-induced pericellular collagenolysis. J Biol Chem 2004, 279:39042-39050
30. Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB: Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 2005, 16:667-675 (Pubitemid 41725103)
31. Kalluri R, Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1784
32. Carpenter PM, Wang-Rodriguez J, Chan OT, Wilczynski SP: Laminin 5 expression in metaplastic breast carcinomas. Am J Surg Pathol 2008, 32:345-353
33. Zhang W, Matrisian LM, Holmbeck K, Vick CC, Rosenthal EL: Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo. BMC Cancer 2006, 6:52